[Androgen therapy for anemia in anephric and regularly dialyzed patients (author's transl)]. 1973

H Hidai, and H Fukuoka, and T Murayama, and T Takeda, and K Ogawa

UI MeSH Term Description Entries
D008297 Male Males
D009392 Nephrectomy Excision of kidney. Heminephrectomy,Heminephrectomies,Nephrectomies
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000728 Androgens Compounds that interact with ANDROGEN RECEPTORS in target tissues to bring about the effects similar to those of TESTOSTERONE. Depending on the target tissues, androgenic effects can be on SEX DIFFERENTIATION; male reproductive organs, SPERMATOGENESIS; secondary male SEX CHARACTERISTICS; LIBIDO; development of muscle mass, strength, and power. Androgen,Androgen Receptor Agonist,Androgen Effect,Androgen Effects,Androgen Receptor Agonists,Androgenic Agents,Androgenic Compounds,Agents, Androgenic,Agonist, Androgen Receptor,Agonists, Androgen Receptor,Compounds, Androgenic,Effect, Androgen,Effects, Androgen,Receptor Agonist, Androgen,Receptor Agonists, Androgen
D000740 Anemia A reduction in the number of circulating ERYTHROCYTES or in the quantity of HEMOGLOBIN. Anemias

Related Publications

H Hidai, and H Fukuoka, and T Murayama, and T Takeda, and K Ogawa
December 1973, Kidney international,
H Hidai, and H Fukuoka, and T Murayama, and T Takeda, and K Ogawa
April 1979, Kidney international,
H Hidai, and H Fukuoka, and T Murayama, and T Takeda, and K Ogawa
June 1979, Nihon Jinzo Gakkai shi,
H Hidai, and H Fukuoka, and T Murayama, and T Takeda, and K Ogawa
December 1981, [Rinsho ketsueki] The Japanese journal of clinical hematology,
H Hidai, and H Fukuoka, and T Murayama, and T Takeda, and K Ogawa
July 1979, Medicina clinica,
H Hidai, and H Fukuoka, and T Murayama, and T Takeda, and K Ogawa
March 1986, Ceskoslovenska patologie,
H Hidai, and H Fukuoka, and T Murayama, and T Takeda, and K Ogawa
January 1975, Klinische Wochenschrift,
H Hidai, and H Fukuoka, and T Murayama, and T Takeda, and K Ogawa
September 1974, [Rinsho ketsueki] The Japanese journal of clinical hematology,
H Hidai, and H Fukuoka, and T Murayama, and T Takeda, and K Ogawa
January 1978, Czechoslovak medicine,
H Hidai, and H Fukuoka, and T Murayama, and T Takeda, and K Ogawa
June 1981, Casopis lekaru ceskych,
Copied contents to your clipboard!